BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31241363)

  • 1. FACTORS INFLUENCING THE SUCCESSFUL MAINTENANCE OF EUTHYROIDISM AFTER LOBECTOMY IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA: A SINGLE-CENTER STUDY.
    Ha TK; Kim DW; Park HK; Lee YJ; Jung SJ; Baek HJ
    Endocr Pract; 2019 Oct; 25(10):1035-1040. PubMed ID: 31241363
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors associated with postoperative hypothyroidism after lobectomy in papillary thyroid microcarcinoma patients.
    Park HK; Kim DW; Ha TK; Choo HJ; Park YM; Jung SJ; Kim DH; Bae SK
    Endocr Res; 2015; 40(1):49-53. PubMed ID: 25111668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of thyroid hormone supplementation after thyroid lobectomy.
    Lee DY; Seok J; Jeong WJ; Ahn SH
    J Surg Res; 2015 Jan; 193(1):273-8. PubMed ID: 25088372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features of Early and Late Postoperative Hypothyroidism After Lobectomy.
    Park S; Jeon MJ; Song E; Oh HS; Kim M; Kwon H; Kim TY; Hong SJ; Shong YK; Kim WB; Sung TY; Kim WG
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1317-1324. PubMed ID: 28324106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the factors affecting the efficacy of (131)I remnant ablation in patients after thyroidectomy for papillary thyroid microcarcinoma].
    Du F; Hu S; Wu C; Cheng Y; Wu LX; Liu JZ; Wu ZF; Li SJ
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):610-613. PubMed ID: 30139032
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer.
    Tam AA; Ozdemir D; Aydın C; Bestepe N; Ulusoy S; Sungu N; Ersoy R; Cakir B
    Endocrine; 2018 Mar; 59(3):565-572. PubMed ID: 29374347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression.
    Na YM; Cho JS; Park MH
    Anticancer Res; 2021 Nov; 41(11):5713-5721. PubMed ID: 34732444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.
    Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
    Surgery; 2017 Feb; 161(2):485-492. PubMed ID: 27593085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.
    Ito M; Miyauchi A; Kang S; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nakamura H; Amino N
    Eur J Endocrinol; 2015 Sep; 173(3):333-40. PubMed ID: 26077156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between serum thyroxin-stimulating hormone and papillary thyroid micrcarcinoma in nodular thyroid disease].
    Jiao J; Zhou Y
    Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(12):908-11. PubMed ID: 26081052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up ultrasonography after lobectomy in papillary thyroid microcarcinoma patients: A single-center study.
    Kim DW
    Endocr Res; 2016 Aug; 41(3):213-7. PubMed ID: 26864682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation for papillary thyroid microcarcinoma close to the thyroid capsule versus far from the thyroid capsule: a retrospective study.
    Luo J; Hui T; Jin P; Sun Y; Chen Y; Lin Z; Huang P
    Endokrynol Pol; 2024; 75(1):35-41. PubMed ID: 38497388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma.
    Ahn D; Lee GJ; Sohn JH; Jeon JH
    Head Neck; 2020 May; 42(5):1004-1013. PubMed ID: 31930773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The magnitude of increased Levothyroxine dose during pregnancy in patients on thyroid-stimulating hormone (TSH) suppression treatment after total thyroidectomy for papillary carcinoma.
    Minakata M; Ito M; Kishi T; Hada M; Masaki Y; Nakamura T; Kousaka K; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
    Endocr J; 2022 Feb; 69(2):165-172. PubMed ID: 34526424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
    Xia Q; Dong S; Bian PD; Wang J; Li CJ
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1037-43. PubMed ID: 25744048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
    Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid stimulating hormone suppression and recurrence after thyroid lobectomy for papillary thyroid carcinoma.
    Bae MR; Nam SH; Roh JL; Choi SH; Nam SY; Kim SY
    Endocrine; 2022 Feb; 75(2):487-494. PubMed ID: 34689317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study.
    Le Moli R; Malandrino P; Russo M; Tumino D; Piticchio T; Naselli A; Rapicavoli V; Belfiore A; Frasca F
    Endocrinol Diabetes Metab; 2023 Mar; 6(2):e406. PubMed ID: 36722311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up.
    Kim SY; Kim HJ; Kim SM; Chang H; Lee YS; Chang HS; Park CS
    Front Endocrinol (Lausanne); 2020; 11():520. PubMed ID: 32849303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.